Literature DB >> 2867953

Inhibition of acid and gastric carcinoids.

J B Elder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867953      PMCID: PMC1433111          DOI: 10.1136/gut.26.12.1279

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  28 in total

1.  Letter: ECL cell proliferation and gastrin levels.

Authors:  C Bordi; A Costa; G Missale
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

Review 2.  Endocrine cells of the gastrointestinal tract and related tumors.

Authors:  E Solcia; C Capella; R Buffa; L Usellini; B Frigerio; P Fontana
Journal:  Pathobiol Annu       Date:  1979

Review 3.  [Hyperplasias and tumours of the disseminated endocrine (paracrine) helle zellen Feyrter's of the gut with special regard of amphicrine cell proliferations (author's transl)].

Authors:  M Ratzenhofer
Journal:  Verh Dtsch Ges Pathol       Date:  1977

4.  Qualitative and quantitative studies of antral and fundic G cells in pernicious anaemia.

Authors:  J M Polak; A V Hoffbrand; P I Reed; S Bloom; A G Pearse
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Carcinoid tumors. A study of 204 cases.

Authors:  S I Hajdu; S J Winawer; W P Myers
Journal:  Am J Clin Pathol       Date:  1974-04       Impact factor: 2.493

6.  A fine structural characterization of the proliferated endocrine cells in atrophic gastric mucosa.

Authors:  W Rubin
Journal:  Am J Pathol       Date:  1973-01       Impact factor: 4.307

7.  Endocrine cells of the gastric mucosa.

Authors:  E Solcia; C Capella; G Vassallo; R Buffa
Journal:  Int Rev Cytol       Date:  1975

8.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

9.  Cimetidine and gastric cancer.

Authors:  J B Elder; P C Ganguli; I E Gillespie
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

10.  Radioimmunoassay of plasmagastrin in pernicious anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls.

Authors:  P C Ganguli; D R Cullen; W J Irvine
Journal:  Lancet       Date:  1971-01-23       Impact factor: 79.321

View more
  6 in total

1.  Calbindin immunoreactivity is a characteristic of enterochromaffin-like cells (ECL cells) of the human stomach.

Authors:  J B Furness; R T Padbury; K G Baimbridge; J M Skinner; D E Lawson
Journal:  Histochemistry       Date:  1989

2.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

Review 4.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

5.  Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade.

Authors:  D Poynter; S A Selway; S A Papworth; S R Riches
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

Review 6.  The consequences of hypergastrinemia.

Authors:  W Creutzfeldt
Journal:  Yale J Biol Med       Date:  1994 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.